Contact SCGE




SCGE Consortium Home   |  About SCGE Toolkit   |  Contact Us   |  Citing the Toolkit   |  License  
 
Filters ..
  Tissues
Respiratory
  • Epithelium of bronchiole  (TARGET)
  • Epithelium of main bronchus  (TARGET)
  Editors
 Alt-R® S.p. Cas9 Nuclease V3
 AsCas12a (IDT and Feldan Therapeutics)
  Guide Target Locus
 Ai9/Ai14 reporter transgene
 Ai9/Ai14 reporter transgene (within loxP)
  Guides
 g-loxP2_C9
 g-loxPbot_C12a
Delivery Systems
 S10
Models
 mTmG mouse
Select experimental variable to highlight records on the chart: 
 

Note: Hover over the bars to view additional information

Loading...

Results

Shuttle_peptides_enable_in_vivo_gene_editing_with_Cas9_and_Cas12a_RNP_in_mouse_airway_epithelia_
Editing Efficiency
Record Id Condition Tissue Editor Model Delivery Target Locus Guide Dosage Injection Frequency Editing Efficiency % of cells Image
15000000278 S10, Cas9 epithelium of bronchiole (TARGET) Alt-R® S.p. Cas9 Nuclease V3 mTmG mouse S10 Ai9/Ai14 reporter transgene g-loxP2_C9 [S10]: 40 µM; [Cas9]: 1.33 µM; [gRNA]: 2 µM once
15000000279 S10, Cas12a epithelium of bronchiole (TARGET) AsCas12a (IDT and Feldan Therapeutics) mTmG mouse S10 Ai9/Ai14 reporter transgene (within loxP) g-loxPbot_C12a [S10]: 40 µM; [Cas12a): 2.5 µM; [gRNA]: 2 µM twice
15000000282 S10, Cas9 epithelium of main bronchus (TARGET) Alt-R® S.p. Cas9 Nuclease V3 mTmG mouse S10 Ai9/Ai14 reporter transgene g-loxP2_C9 [S10]: 40 µM; [Cas9]: 1.33 µM; [gRNA]: 2 µM once
15000000283 S10, Cas12a epithelium of main bronchus (TARGET) AsCas12a (IDT and Feldan Therapeutics) mTmG mouse S10 Ai9/Ai14 reporter transgene (within loxP) g-loxPbot_C12a [S10]: 40 µM; [Cas12a): 2.5 µM; [gRNA]: 2 µM twice

Publication Title
Engineered amphiphilic peptides enable delivery of proteins and CRISPR-associated nucleases to airway epithelia. NCBI

S10 peptide delivery of Cas9 RNP shows editing in ROSAmT/mG locus in vivo

S10 peptide delivery of Cas9 RNP shows editing in ROSAmT/mG locus in vivo. Cas9 RNP directed to loxP sites flanking the tdTomato cassette were administered with S10 peptide once daily on 2 consecutive days. Seven days later, conversion of tdTomato to GFP expression was visualized in lung tissue sections. A) Schematic of gRNA targeting two loxP sequences flanking tdTomato gene and experimental protocol for Cas9 RNP delivery to ROSAmT/mG mice. B) Fluorescence image of large airway 7 days following two intranasal doses of [S10]: 40 µM; [Cas9]: 1.33 µM; [gRNA]: 2 µM; ×2 magnification. GFP expression denotes edited cells. C) Editing in a large airway, ×20 magnification. D) Editing in a small airway; ×20 magnification. E) Co-localization of GFP and marker of ciliated cells (α-tubulin, white) in large airway. Arrows indicate α-tubulin co-localization with GFP. Arrowheads denote edited (GFP+) nonciliated cells negative for α-tubulin; ×40 magnification. F) Co-localization of GFP+ and SP-C (white) identifies alveolar type II cells (arrows) in distal lung; ×40 magnification. G) Representative image of large airway after delivery of Cas9 RNP alone shows no editing, ×20 magnification. H) Representative image of small airways after delivery of Cas9 RNP alone shows no editing; ×20 magnification. I) Editing efficiency of Cas9 in large and small airways quantified by the number of GFP+ cells. Horizontal lines indicate mean ± SE; n = 5 mice/group. Pubmed  

S10 peptide delivery of Cas12a RNP shows editing in ROSAmT/mG locus in vivo
S10 peptide delivery of Cas12a RNP shows editing in ROSAmT/mG locus in vivo. A) Schematic of Cas12a gRNA targeting both loxP sequences flanking tdTomato gene in ROSAmT/mG mice. S10 peptide and Cas12a RNP (2.5 uM Cas12a; 2.0 uM gRNA) directed to suboptimal PAM target in loxP sites flanking the tdTomato cassette administered twice a day for 2 days, via intranasal instillation. Seven days later, conversion of tdTomato to GFP expression was visualized in lung tissue sections. B) Cas12a mediated deletion of tdTomato in ROSAmT/mG in large airway epithelia in vivo; x2 magnification. C) Editing in a large airway; x20 magnification. D) Editing in a small airway; x20 magnification. E) Co-localization of GFP and marker of ciliated cells (a-tubulin, white) in large airway. Arrowheads indicate GFP and a-tubulin co-localization. Arrow denotes edited (GFP+) non-ciliated cell negative for a±-tubulin; x40 magnification. F) Distal lung region. Co-localization of GFP+ and SP-C (white) identifies alveolar type II cells (arrowhead); x40 magnification. G) Editing efficiency of Cas12a RNP in large and small airways quantified by the number of GFP+ cells. Horizontal lines indicate mean ± SE; n = 3 mice/group. https://doi.org/10.1038/s41467-019-12922-y